TAMARA GORMAN: Open Payments
NPI 1154953099 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,310 in 66 payments from 17 companies in 2025. Trend: 2023 $3,389 · 2024 $3,694 · 2025 $1,310
Food & beverage: $1,310
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $185 |
| Corcept Therapeutics | 8 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $141 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $112 |
| Insulet Corporation | 5 | $102 |
| Radius Health, Inc. | 5 | $77 |
| Novo Nordisk Inc | 4 | $69 |
| Xeris Pharmaceuticals, Inc. | 4 | $67 |
| Sequel Med Tech, LLC | 3 | $62 |
| Lilly USA, LLC | 3 | $60 |
Products named: Bimzelx, Korlym, ISTURISA, Omnipod, Tymlos, TWIIST, Kerendia, Dexcom G6 Transmitter.
Industry payments across IN — which companies pay providers there.
